Several private equity firms and German PE-backed drugmaker Stada have submitted bids for the acquisition of Upsa, a French division of New York-based pharmaceutical giant Bristol-Myers Squibb, according to press reports.
GP invests via its Mandarin Capital Partners III fund, which held a €148m first close in September
Biotech's series-A is supported by a consortium of investors led by existing backer Ahren
YFM Private Equity made a growth investment in the digital post-production company last year
Education institutions and online universities are flourishing in southern Europe, attracting international GPs